Prospective study shows effectiveness of 2% CHG dressings in preventing infections in ICU patients, suggesting better safety measures.
Background and Purpose: Catheter-related bloodstream infections (CRBSIs) remain a significant cause of morbidity and mortality in intensive care units (ICUs). Chlorhexidine gluconate (CHG)-impregnated dressings may reduce catheter colonization and infection. This prospective single-center observational study evaluated the effectiveness and safety of a 2% CHG-containing hydrogel pad dressing in preventing local infection and CRBSI in critically ill adults.Methods: Between June and December 2025, adult ICU patients who underwent jugular or subclavian central venous catheter insertion and received a 2% CHG hydrogel pad dressing were included. Patients were followed daily for seven days and assessed for dermatitis, local infection, and CRBSI.Results: A total of 122 patients (mean age 68.4±16 years; 52.5% male) were included. Only one patient (0.8%) developed a local infection; no CRBSI was observed. The catheter-related infection incidence density was 1.34/1000 catheter-days (95% CI: 0.03–7.48). No dermatitis or allergic reactions occurred. Dressing detachment was noted in 4.1% of cases. Conclusion: The 2% CHG hydrogel pad dressing was associated with low infection rates. Controlled comparative studies are warranted.
No takes yet. Share an insight, caveat, or question.
Atalay et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: